Advertisement

Topics

Regeneron Pharmaceuticals (REGN) Receiving Somewhat Favorable News Coverage, Analysis Shows

01:43 EDT 20 Aug 2017 | Topix

Headlines about Regeneron Pharmaceuticals have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million news and blog sources.

Original Article: Regeneron Pharmaceuticals (REGN) Receiving Somewhat Favorable News Coverage, Analysis Shows

NEXT ARTICLE

More From BioPortfolio on "Regeneron Pharmaceuticals (REGN) Receiving Somewhat Favorable News Coverage, Analysis Shows"

Advertisement
Quick Search
Advertisement
Advertisement